CDC discusses resuming Johnson & Johnson COVID-19 vaccine use – CBS News
A CDC advisory committee reconvened on Friday to discuss whether it’s safe to resume administering the Johnson and Johnson one-dose COVID-19 vaccine. This comes after several people reported developing blood clots after receiving the shot. At least two people have died as a result of those clots. Tanya Rivero spoke with Dr. William Schaffner, professor of Infectious Diseases at Vanderbilt University Medical Center, about what outcome we can expect from the meeting.
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.